Tissue engineering is quickly growing in popularity as a way to address specific
medical needs such as organ failure and significant tissue injury. It allows tissue
regeneration in situations where spontaneous regeneration is impossible. Tissue
engineering, in a nutshell, allows the body to mend itself. However, there are risks
associated with altering this tissue - medical engineering developments.
Tumourigenicity, graft rejection, immunogenicity, and cell migration are the key
dangers in tissue engineering, in my opinion.
Tumourigenicity
A tumor is an abnormal growth of cells within the body caused by a lack of
apoptosis (natural cell death), which allows for the uncontrolled proliferation of unwanted
or damaged cells. Tumors can be benign (non-cancerous and typically harmless) or
malignant (cancerous and dangerous) (cancerous, harmful, and can spread further).
Regulatory growth factors are proteins that regulate tissue regeneration and development
in animals. As a result, the careful balance between inhibitory and stimulatory signals
provided by these substances influences many of the parameters surrounding cell
development: proliferation, survival, and certain aspects of cell behavior, as well as cell
differentiation.
Graft Rejection
Graft rejection occurs when the recipient's immune system assaults the given tissue
or organ and begins to destroy it. The presence of the donor's own unique set of HLA
proteins, which the recipient's immune system recognizes as alien, frequently triggers the
immunological response.
Immunogenicity
Immunogenicity is described as a cell's or tissue's ability to elicit an immunological
response, which is often seen as a negative physiological reaction. Immunogenicity is a
negative trait. Some people's systems reject monoclonal antibodies, potentially rendering
them useless or causing an allergic reaction or other negative side effects.
